Churl-Su Kwon

Department of Integrated Biological science, Pusan National University, Busan, Republic of Korea.

50 publications 2022 – 2026 ORCID

What does Churl-Su Kwon research?

Churl-Su Kwon's research primarily targets acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow. They investigate various drugs, including antiviral medications originally used for HIV and hepatitis B, to see if these can force leukemia cells to mature into non-cancerous cells and die. Kwon's studies have also explored the therapeutic potential of natural compounds and have provided insights into treatment strategies that could alter existing cancer therapies. Additionally, Kwon conducts research concerning epilepsy, examining how new tools can enhance the diagnosis and treatment of patients with this neurological disorder, especially those who also have other conditions like autism.

Key findings

  • Tenofovir alafenamide induced differentiation and apoptosis of AML cells, increasing chemotherapy's effectiveness in patient-derived samples.
  • Azvudine emerged as a potent candidate for AML treatment by blocking telomerase, showing effects in samples with high-risk mutations.
  • Surgery for epilepsy in patients with autism resulted in seizure freedom for 54% of participants, with significant improvements in behavior and quality of life.
  • MiR-124 was shown to halt leukemia cell division and trigger cell death by restoring its levels, representing a potential RNA-based therapy.
  • Visomitin shrank tumors in mouse models of AML and demonstrated selective toxicity against leukemia cells.

Frequently asked questions

Does Dr. Kwon study acute myeloid leukemia?
Yes, Dr. Kwon focuses extensively on acute myeloid leukemia, looking for new treatment strategies to induce cell maturity and death.
What treatments has Dr. Kwon researched for leukemia?
Dr. Kwon has researched several treatments, including the antiviral drugs tenofovir alafenamide and azvudine, which show promise in forcing leukemia cells to mature.
Is Dr. Kwon's work relevant to patients with epilepsy?
Yes, Dr. Kwon investigates tools for improving epilepsy diagnosis and treatment, particularly in patients with overlapping conditions like autism.
What improvements have been found in epilepsy surgery outcomes?
Their research indicates that epilepsy surgery can lead to seizure freedom in over half of the patients with comorbid autism, along with better behavioral outcomes.
Has Dr. Kwon found any natural compounds effective against leukemia?
Yes, Dr. Kwon studied several natural compounds, including protopine and Picroside III, both of which demonstrated anti-leukemic properties.

Publications in plain English

Seizure outcomes in persons with autism spectrum disorder undergoing epilepsy surgery: A systematic review and meta-analysis.

2026

Epilepsia

Subramaniam VR, Goldstein J, Rafati A, Gorka P, Kwon CS

Plain English
This systematic review pooled outcomes from 325 patients with both autism and drug-resistant epilepsy who underwent surgery. Surgical removal of brain tissue led to seizure freedom in 54% of patients, and brain stimulation devices reduced seizures by more than 80% in roughly one-third; patients with visible abnormalities on MRI and seizures originating in the temporal lobe did best. Most patients also showed improvement in behavior or quality of life after surgery, supporting surgical evaluation for well-selected patients with this dual diagnosis.

PubMed

MicroRNA-124 induces AML differentiation and apoptosis through c-Myc suppression.

2026

Genes & genomics

Jeon BE, Kwon CS, Lee JE, Lee SJ, Song K +3 more

Plain English
A small RNA molecule called miR-124 is typically suppressed in AML, and researchers showed that restoring its levels forces leukemia cells to stop dividing, mature, and die. The mechanism involves miR-124 raising reactive oxygen species levels, which then shut down the cancer-promoting protein c-Myc — and c-Myc itself represses miR-124, creating a feedback loop that keeps leukemia going. Delivering miR-124 inside exosomes also reduced AML cell survival, pointing toward a potential RNA-based therapy.

PubMed

Methodologies for developing and applying consensus-based recommendations in epilepsy care: A narrative review.

2026

Epilepsia

Haffner R, Mathew B, Brigo F, Qasim A, Antonio-Arce VS +10 more

Plain English
This review compared three structured methods — Delphi, nominal group technique, and the RAND/UCLA Appropriateness Method — used to build expert consensus recommendations when clinical trial evidence is limited or absent. The Delphi technique dominated epilepsy research (58 of 64 consensus studies), particularly for guiding management of rare or complex conditions like refractory seizures in pregnancy. The choice of method depends on available resources and whether rapid, in-person consensus is needed versus iterative anonymous rounds.

PubMed

Validation of the International League Against Epilepsy (ILAE) Risk of Bias Tool against the Newcastle-Ottawa Scale in epilepsy research.

2026

Epilepsia

Kwon CS, Rafati A, Jette N, Newton CR

Plain English
Researchers tested whether a new epilepsy-specific tool for rating the quality of observational studies (the ILAE Risk of Bias Tool) gives results consistent with the well-established Newcastle-Ottawa Scale. Across 54 studies on psychiatric conditions in people with epilepsy, the two tools showed strong agreement and the ILAE tool had excellent reproducibility when used by the same rater on different occasions. The ILAE tool can reliably replace general-purpose tools in epilepsy evidence reviews while also capturing disease-specific details those tools miss.

PubMed

Visomitin as a differentiation-inducing therapeutic agent through SYK inhibition in AML.

2026

Frontiers in pharmacology

Jeon BE, Kwon CS, Lee JE, Lee SJ, Cho Y +3 more

Plain English
Visomitin, a drug originally developed to protect mitochondria, was tested in AML cells to see if it could force leukemia cells to differentiate and die. It raised reactive oxygen species specifically inside AML cells, which then inhibited a protein called SYK, pushing cells toward maturity while reducing proteins that normally keep cancer cells alive. It shrank tumors in mice and suppressed growth in patient-derived AML samples, suggesting selective toxicity against leukemic cells.

PubMed

Tenofovir Alafenamide Promotes Differentiation and Induces Apoptosis of AML Cells by Inhibiting Telomerase Reverse Transcriptase.

2026

Anticancer research

Lee JE, Jeon BE, Kwon CS, Lee SJ, Seo Y +2 more

Plain English
Researchers screened 100 FDA-approved drugs to find ones that can push acute myeloid leukemia (AML) cells to mature into normal, non-dividing cells. Tenofovir alafenamide, an antiviral drug used for HIV and hepatitis B, turned out to kill AML cells and force them to differentiate by blocking an enzyme called telomerase and triggering cellular stress signals. It also worked in cancer cells taken directly from patients and boosted the effect of standard chemotherapy, making it a candidate for repurposing as an AML treatment.

PubMed

Prevalence of epilepsy: a population-based cohort study in Denmark with comparison to Global Burden of Disease (GBD) prevalence estimates.

2025

Journal of neurology, neurosurgery, and psychiatry

Christensen J, Trabjerg BB, Wagner RG, Newton CR, Kwon CS +8 more

Plain English
Using Danish national registry data, researchers counted all people diagnosed with epilepsy and filled an antiseizure medication prescription in 2018 and compared their prevalence figures to global estimates from the Global Burden of Disease study. Denmark's overall epilepsy prevalence of 697 per 100,000 closely matched the GBD global estimate of 682, and perinatal injury, traumatic brain injury, brain tumors, and stroke were the leading identifiable causes. The study recommends that future global estimates explicitly include epilepsy from known underlying causes rather than treating them only as sequelae of other diseases.

PubMed

Psychiatric Comorbidities in Persons With Epilepsy Compared With Persons Without Epilepsy: A Systematic Review and Meta-Analysis.

2025

JAMA neurology

Kwon CS, Rafati A, Ottman R, Christensen J, Kanner AM +2 more

Plain English
This large meta-analysis pooled data from 27 studies covering over 565,000 people with epilepsy and 13 million without to quantify the odds of 20 psychiatric disorders in epilepsy. Nearly every psychiatric condition examined — including depression, anxiety, schizophrenia, ADHD, autism, and alcohol dependence — was significantly more common in people with epilepsy, with odds ratios ranging from roughly 2 to 11. The scale of the psychiatric burden highlights the need for routine mental health screening and integrated care in epilepsy.

PubMed

Norchelerythrine from(Thunb.) Pers. promotes differentiation and apoptosis by activating DNA damage response in acute myeloid leukemia.

2025

International journal of oncology

Lee JE, Jeon BE, Kwon CS, Kim HY, Kim TJ +4 more

Plain English
Screening 100 South Korean plant extracts, researchers identified Chelidonium incisum (a wild plant from the poppy family) as strongly capable of pushing AML cells toward maturity. They isolated norchelerythrine as the active compound responsible, showing it triggers DNA damage signaling through reactive oxygen species and upregulates the cell-cycle inhibitor p21, leading to differentiation and cell death across multiple AML cell lines and patient samples with different genetic mutations. Norchelerythrine may represent a new natural compound for AML differentiation therapy.

PubMed

Therapeutic Potential ofHance Stem and Picroside III as a Differentiation Inducer in AML Cells via Mitochondrial ROS Accumulation.

2025

International journal of molecular sciences

Kwon CS, Jeon BE, Lee JE, Kim HY, Kang RY +6 more

Plain English
Researchers screened 200 plant extracts and identified the stem of the Akebia rhizome (ARH) as a potent inducer of AML cell maturation, then used chemical analysis to isolate Picroside III as the key active compound. Both the crude stem extract and isolated Picroside III forced AML cells to differentiate, slowed proliferation, and increased mitochondrial reactive oxygen species, which drove the anti-leukemic effects. The findings establish Picroside III as a natural compound worth developing further for AML differentiation therapy.

PubMed

Clinical effectiveness, feasibility, acceptability, and usability of mobile health applications for epilepsy: A systematic review.

2025

Epilepsia

Gotlieb E, Marzoughi S, Kwon CS, Harmon M, Kimura M +7 more

Plain English
This systematic review examined 20 studies to evaluate whether epilepsy smartphone apps actually improve patient outcomes and whether patients find them usable and acceptable. Most studies focused on medication tracking and symptom logging, and results were mixed — randomized trials showed some concern for bias and cohort studies were only fair quality — while usability studies rated highly. Stronger, more standardized evidence is needed before apps can be broadly recommended as clinical tools in epilepsy care.

PubMed

Elevated suicide risk in individuals with epilepsy: a systematic review and meta-analysis.

2025

Journal of neurology

Rafati A, Pasebani Y, Kwon CS

Plain English
This meta-analysis pooled data from 13 studies to quantify how much more often people with epilepsy think about, attempt, or complete suicide compared to those without epilepsy. The risk was roughly doubled for suicidal ideation, more than tripled for suicide attempts, and more than doubled for completed suicide. The findings call for systematic mental health screening and integrated psychiatric support in epilepsy care.

PubMed

Sex-Specific Patterns of Reproduction in People With Epilepsy: A Nationwide Cohort Study From Denmark.

2025

Neurology

Klakk J, Trabjerg BB, Berkovic SF, Cotsapas C, Kwon CS +3 more

Plain English
Using four decades of Danish national registry data covering over 2.5 million people, this study found that men with epilepsy are far less likely to become parents than women with the condition — 46% of epileptic men remained childless by age 45 versus 31% of epileptic women, compared to 23% and 14% respectively in people without epilepsy. Having both epilepsy and a psychiatric condition was associated with the greatest reduction in likelihood of having children, and focal epilepsy carried lower odds than generalized epilepsy. The gap between men and women with epilepsy was not explained by these factors, signaling unknown biological or social mechanisms.

PubMed

Author Response: Multipsychiatric Comorbidity in People With Epilepsy Compared With People Without Epilepsy: A Systematic Review and Meta-Analysis.

2025

Neurology

Kwon CS, Newton CR, Jette N

PubMed

Clinical strategies for management of abnormal uterine bleeding: hormonal and nonhormonal interventions in women at risk for venous thromboembolism.

2025

Current opinion in obstetrics & gynecology

Kwon CS, Eswaran H, Carey ET

Plain English
This review addresses how to manage heavy or irregular uterine bleeding in women who are also at elevated risk for dangerous blood clots. It outlines six principles for selecting hormonal and non-hormonal therapies, using case examples to show how to weigh clot risk against bleeding control. Non-estrogen options like progestin-only formulations and the anti-clotting drug tranexamic acid are highlighted as safer choices in women with clotting risk factors.

PubMed

Functional Seizures-A Critical Comorbidity Overlooked in Epilepsy Research-Reply.

2025

JAMA neurology

Kwon CS, Jetté N, Newton CR

PubMed

Development and validation of International Classification of Diseases, 9th and 10th Revision, Clinical Modification-based algorithms to identify adult epilepsy in electronic health records.

2025

Epilepsia

Lemus HN, Goldstein J, Tai HH, Lin JY, Kwon CS +7 more

Plain English
This study tested how accurately different combinations of diagnosis codes and prescription data from electronic health records can identify adult epilepsy patients. Ninety-four algorithms were evaluated against chart reviews, and the best-performing ones balanced sensitivity and specificity around 80-95% depending on the goal of the study. The results give researchers practical, validated code combinations to choose from depending on whether their priority is capturing every case or avoiding false positives.

PubMed

Azvudine exhibits potent differentiation-inducing effect by targeting the TERT/p21 axis in acute myeloid leukemia.

2025

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Kwon CS, Lee JE, Jeon BE, Kim TJ, Lee SH +2 more

Plain English
Researchers screened a chemical library looking for drugs that force AML cells to mature, and Azvudine — an antiviral approved in China for HIV — emerged as the most potent candidate. It works mainly by blocking telomerase reverse transcriptase, which shortens telomeres and triggers DNA damage signaling that culminates in cell maturation and death; it also raises mitochondrial stress that promotes apoptosis. The drug reproduced these effects in patient-derived AML samples carrying a range of mutations, including high-risk TP53 mutations, supporting its repositioning as an AML therapy.

PubMed

Twelve-year proportions and causes of admissions among those with neurological conditions in the US: A nationally representative study.

2025

Clinical neurology and neurosurgery

Solmssen C, Agarwal P, Jetté N, Subramaniam VR, Kwon CS

Plain English
Using 12 years of U.S. national hospital data, this study tracked admission trends for eight major neurological conditions from 2003 to 2014. Admissions for nearly all conditions increased as a share of all hospitalizations, and by 2011 septicemia had risen to become a top reason for hospitalization across most of these groups — a shift from earlier years when the neurological condition itself was the primary reason. Many leading causes of admission were potentially preventable, pointing to infection control as a high-priority intervention.

PubMed

Protopine Exerts Anti-Leukemic Effects by Promoting ROS-mediated Inhibition of Survival Signals in Acute Myeloid Leukemia Cells.

2025

Anticancer research

Lee JE, Jeon BE, Kwon CS, Seo Y, Kim SW

Plain English
Protopine, a natural compound found in certain plants, was tested in AML cell lines to see whether it could induce differentiation and cell death. It raised reactive oxygen species in mitochondria, activated cell-cycle brake proteins p16 and p21, disrupted mitochondrial function, and shut down the AKT and ERK survival signals that leukemia cells depend on. These converging effects make protopine a candidate for differentiation-based AML treatment strategies.

PubMed

Responsive Neurostimulation for People With Drug-Resistant Epilepsy and Autism Spectrum Disorder.

2024

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society

Fields MC, Marsh C, Eka O, Johnson EA, Marcuse LV +13 more

Plain English
This multicenter study followed 19 patients with both autism and drug-resistant epilepsy who received the responsive neurostimulation (RNS) system, which detects and responds to abnormal brain activity in real time. Sixty-three percent experienced more than 50% seizure reduction, and 79% showed behavioral improvement on a standardized scale, with no surgical complications reported. The results support RNS as a viable surgical option for people with autism who cannot undergo traditional epilepsy surgery.

PubMed

The Impact of TeamSTEPPS Training on Obstetric Team Attitudes and Outcomes on the Labor and Delivery Unit of a Regional Perinatal Center.

2024

American journal of perinatology

Kwon CS, Duzyj C

Plain English
This study evaluated whether TeamSTEPPS — a structured teamwork training program — improved attitudes about patient safety and reduced complication rates on a labor and delivery unit. Surveys before and six months after training showed no significant change in teamwork perceptions overall, and physicians and nurses differed notably in their views, with nurses reporting more negative perceptions after training. Objective obstetric complication rates were also unchanged, suggesting that a single training intervention without sustained reinforcement is unlikely to produce measurable improvements.

PubMed

Older adults with epilepsy and COVID-19: Outcomes in a multi-hospital health system.

2024

Seizure

Ufongene C, Van Hyfte G, Agarwal P, Goldstein J, Mathew B +14 more

Plain English
This retrospective study examined 5,384 older adults (65 and up) hospitalized with COVID-19 at a large New York health system, comparing the 173 who had epilepsy to those without. After adjusting for age and other medical conditions, older adults with epilepsy were 55% more likely to die in hospital, more than three times as likely to not return home after discharge, and had hospital stays nearly 50% longer. The results identify epilepsy as an independent risk factor for severe COVID-19 outcomes in the elderly.

PubMed

Health care access, psychosocial outcomes and mental health in adults living with epilepsy during the COVID-19 pandemic.

2024

Epilepsy & behavior : E&B

Mc Carthy L, Mathew B, Blank LJ, Van Hyfte G, Gotlieb E +11 more

Plain English
A cross-sectional survey of 55 adults with epilepsy at a multicenter New York health system assessed mental health, financial well-being, medication access, and seizure burden during the COVID-19 pandemic. Over half screened positive for depression and nearly a third for anxiety, with many reporting these as new symptoms since the pandemic began; 25% lost jobs and 40% reported worsened financial stress. Healthcare access was relatively preserved — most cancelled visits were converted to telehealth — but the findings point to ongoing need for psychosocial support in this population.

PubMed

Disparities in Teleneurology Use in Medicaid Beneficiaries With Epilepsy by Practice Setting: Promoting Health Equity in Academic Centers.

2024

Neurology

Gotlieb E, Agarwal P, Blank LJ, Kwon CS, Muxfeldt M +2 more

Plain English
This study used electronic health records from a large New York City health system to compare telehealth use between Medicaid patients with epilepsy seen in a segregated Medicaid-only clinic versus those integrated into a general faculty practice. Medicaid patients in the Medicaid-only setting were significantly less likely to use telehealth than either Medicaid patients in the integrated setting or non-Medicaid patients, a disparity that persisted after adjustment. Integration of Medicaid patients into standard care settings was associated with equalized telehealth access, suggesting structural segregation — not insurance type alone — drives the disparity.

PubMed

Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study.

2024

Journal of neurology

Gururangan K, Peschansky VJ, Van Hyfte G, Agarwal P, Blank LJ +29 more

Plain English
This cohort study described neurological and psychiatric complications among nearly 1,000 COVID-19 patients hospitalized across a large New York City health system in 2020-2021. Nearly 60% experienced some neuropsychiatric complication, with altered mental status being the most common; this complication was strongly linked to in-hospital death, which occurred in 22% of patients. Anticoagulation therapy was associated with lower odds of death and altered mental status, suggesting a protective role for blood thinners in COVID-19 patients with neurological complications.

PubMed

Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

2024

JAMA neurology

Rafati A, Jameie M, Amanollahi M, Pasebani Y, Jameie M +10 more

Plain English
This meta-analysis of six randomized controlled trials compared seizure incidence in over 63,000 COVID-19 vaccine recipients versus 54,000 placebo recipients. No statistically significant difference in new-onset seizures was found in the 28 days after injection or over the full blinded period of the trials. The results provide robust placebo-controlled evidence that COVID-19 vaccines do not cause new seizures in the general population.

PubMed

(Nakai) K. Bremer and Humphries Extract Limits MYC Expression to Induce Apoptosis in Diffuse Large B Cell Lymphoma.

2024

Current issues in molecular biology

Woo YR, Kwon CS, Lee JE, Jeon BE, Kim TJ +3 more

Plain English
Researchers screened 100 Korean plant extracts for activity against diffuse large B-cell lymphoma (DLBCL), a common and often treatment-resistant blood cancer, and identified an extract from Aster pseudoglehnii (APKH) as the most potent candidate. APKH killed DLBCL cells by suppressing the MYC oncogene and disrupting the mitochondrial proteins that keep cancer cells alive, and it boosted the effectiveness of standard doxorubicin chemotherapy. Chemical profiling identified compounds in the extract likely responsible for these effects, supporting further study of APKH as an adjunct to CHOP chemotherapy.

PubMed

A knowledge synthesis of health research reporting standards relevant to epilepsy surgery.

2024

Epilepsia

Kwon CS, Chua MMJ, Jetté N, Rolston JD

Plain English
This study catalogued all 561 health research reporting standards in the EQUATOR repository to determine which ones apply to epilepsy surgery research. Of 181 applicable standards, only one was epilepsy-specific, and none required reporting of key epilepsy surgery details like duration of illness or MRI findings. The absence of epilepsy surgery-specific reporting standards limits the quality and comparability of the literature and calls for developing field-specific guidelines.

PubMed

Multipsychiatric Comorbidity in People With Epilepsy Compared With People Without Epilepsy: A Systematic Review and Meta-analysis.

2024

Neurology

Kwon CS, Rafati A, Gandy M, Scott A, Newton CR +1 more

Plain English
This systematic review and meta-analysis examined how often people with epilepsy have two or more psychiatric conditions simultaneously — a concept called multipsychiatric comorbidity. Across 15 high-quality studies, people with epilepsy had significantly higher rates of co-occurring conditions, such as depression plus anxiety (9.2% vs. 2.4% in those without epilepsy) and depression plus ADHD (14.4% vs. 3.9%). Surprisingly few studies have directly measured this psychiatric stacking effect, representing a gap in understanding how multiple mental health conditions together affect epilepsy outcomes.

PubMed

In-hospital outcomes in people with autism and epilepsy - A population-based study.

2024

Epilepsy research

Subramaniam VR, Goldstein J, Mu L, Kwon CS

Plain English
Using 12 years of U.S. national inpatient data, this study compared hospital outcomes for patients with both autism and epilepsy against those with epilepsy alone. Patients with both conditions had higher in-hospital death rates, more transfers to other facilities, longer hospital stays, and higher rates of blood infections compared to matched patients with epilepsy only. The findings indicate that the combination of autism and epilepsy creates a distinct clinical profile requiring specialized, proactive hospital management.

PubMed

A Case of a Prolapsing Cervical Myoma Managed With Robot-Assisted Total Laparoscopic Hysterectomy.

2024

Journal of minimally invasive gynecology

Silverstein RG, Kwon CS, Satterfield N, Schiff LD

PubMed

Association of new onset seizure and COVID-19 vaccines and long-term follow-up: A systematic review and meta-analysis.

2024

Epilepsia

Rafati A, Jameie M, Amanollahi M, Pasebani Y, Salimi N +6 more

Plain English
This meta-analysis pooled data from 40 studies — including seven in a formal meta-analysis — to determine whether COVID-19 vaccines increase the risk of new-onset seizures. Across more than 26 million vaccine recipients compared to unvaccinated individuals, and across mRNA versus viral vector vaccines, there was no statistically significant difference in seizure risk in the 21-28 days after vaccination. People with epilepsy and their clinicians can be reassured that COVID-19 vaccines do not appear to raise the risk of first-time seizures.

PubMed

Association of first antiseizure medication with acute health care utilization in a cohort of adults with newly diagnosed epilepsy.

2024

Epilepsia

Blank LJ, Agarwal P, Kwon CS, Boockvar K, Jetté N

Plain English
Analyzing insurance claims for nearly 15,000 adults newly diagnosed with epilepsy, this study found that patients prescribed medications that guidelines recommend against were significantly more likely to visit the emergency department or be hospitalized than those on recommended drugs. About 4% of patients received an explicitly discouraged medication as their first prescription, even though levetiracetam — a guideline-preferred option — accounted for over half of all first prescriptions. The findings reinforce that first medication choice matters for healthcare utilization even beyond direct seizure control.

PubMed

Complications of Deep Brain Stimulation for Parkinson Disease and Relationship between Micro-electrode tracks and hemorrhage: Systematic Review and Meta-Analysis.

2023

World neurosurgery

Rasiah NP, Maheshwary R, Kwon CS, Bloomstein JD, Girgis F

Plain English
This systematic review and meta-analysis of 262 studies covering 21,261 patients with Parkinson's disease summarized complication rates after deep brain stimulation surgery. Device revision (4.9%) and infection (4.2%) were most common, while the symptomatic bleeding rate was 2.4%; importantly, using more than one microelectrode recording track during surgery significantly and non-linearly increased bleeding risk, though a single track did not. The data help surgeons weigh the benefits of precise electrode placement against the incremental hemorrhage risk of additional recording tracks.

PubMed

Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis.

2023

Crohn's & colitis 360

Panaccione R, Collins EB, Melmed GY, Vermeire S, Danese S +7 more

Plain English
This Bayesian network meta-analysis compared nine advanced therapies for moderate-to-severe ulcerative colitis across 23 randomized trials to rank their efficacy and safety in both newly treated and previously treated patients. Upadacitinib ranked highest for inducing and maintaining clinical remission and endoscopic improvement, particularly in patients who had not previously received biologics. Safety profiles were broadly similar across drugs, with no advanced therapy showing a significant increase in serious infections compared to placebo.

PubMed

Seizure onset patterns predict outcome after stereo-electroencephalography-guided laser amygdalohippocampotomy.

2023

Epilepsia

Michalak AJ, Greenblatt A, Wu S, Tobochnik S, Dave H +18 more

Plain English
This five-center retrospective study examined whether the pattern of electrical activity at the start of a seizure — recorded with depth electrodes — could predict success after laser ablation of the hippocampus in temporal lobe epilepsy patients. Overall two-year seizure freedom was only 36%, but patients whose seizures started with low-voltage fast activity or low-frequency spiking had a 46% chance of freedom, while those with slower onset patterns had 0% — a highly significant difference. These findings support using seizure onset patterns to better select patients likely to benefit from this minimally invasive procedure.

PubMed

Association of first anti-seizure medication choice with injuries in older adults with newly diagnosed epilepsy.

2023

Seizure

Blank LJ, Agarwal P, Kwon CS, Jetté N

Plain English
This retrospective cohort study examined whether older adults (50+) with newly diagnosed epilepsy who received a guideline-discouraged antiseizure medication were more likely to suffer injuries like falls or burns within a year. After adjusting for confounders, medication category was not significantly associated with injury, but taking multiple antiseizure medications simultaneously was — as was older age, prior injuries, and traumatic brain injury history. The results suggest that reducing polypharmacy may be a more actionable injury-prevention target than medication choice alone in older adults with epilepsy.

PubMed

Anti-Leukemic Effects ofMaxim Branch on Human B-Cell Acute Lymphoblastic Leukemia Cells.

2023

Current issues in molecular biology

Kwon CS, Lee JE, Jeon BE, Woo YR, Kim YS +4 more

Plain English
Researchers screened 100 South Korean plant extracts and identified a branch extract from Ilex macropoda Miq. as the most potent killer of B-cell acute lymphoblastic leukemia (B-ALL) cells while sparing normal bone marrow cells. The extract triggered leukemia cell death by disrupting mitochondrial function and reducing anti-apoptotic proteins, while also pushing cells toward a more mature state. It also restored sensitivity to glucocorticoids in resistant cells by increasing glucocorticoid receptor levels and suppressing key survival signaling pathways, making it a candidate for relapsed or refractory B-ALL.

PubMed

In-hospital outcomes in patients with and without epilepsy diagnosed with COVID-19-A cohort study.

2023

Epilepsia

Ufongene C, Van Hyfte G, Agarwal P, Blank LJ, Goldstein J +29 more

Plain English
This retrospective cohort study compared COVID-19 outcomes in 334 patients with epilepsy versus over 9,000 without epilepsy across a New York City health system. People with epilepsy were more likely to need ventilators, be admitted to the ICU, and stay longer, but after adjusting for age and other health conditions, only longer hospital stays and higher rates of non-home discharge remained significantly elevated — not mortality. Older age, ventilator use, and higher overall disease burden were the main drivers of death in the epilepsy group.

PubMed

Sensitivity and specificity of alternative screening methods for systematic reviews using text mining tools.

2023

Journal of clinical epidemiology

Li J, Kabouji J, Bouhadoun S, Tanveer S, Filion KB +19 more

Plain English
This study tested whether text mining (TM) software could help researchers screen citations more efficiently when conducting systematic reviews, without sacrificing accuracy. Five screening strategies using three TM tools were compared against a gold-standard double-review process, and TM-assisted methods matched or slightly exceeded the conventional approach while saving about 216 minutes per 500 citations. TM-assisted screening offers a practical time savings while maintaining the sensitivity needed to catch all relevant studies.

PubMed

Updates on the Surgical Approach to Fibroids: The Importance of Radiofrequency Ablation.

2023

Seminars in interventional radiology

Kwon CS, Abu-Alnadi ND

Plain English
This review covers radiofrequency ablation (RFA) as a minimally invasive treatment for uterine fibroids, which affect the majority of women and often cause heavy bleeding, pelvic pain, and fertility problems. RFA uses heat to destroy fibroid tissue while preserving the uterus, and growing evidence shows it is safe and effective with low complication rates and promising fertility outcomes. It is now an established alternative to hysterectomy for women who want to keep their uterus or future fertility.

PubMed

Comparing vagus nerve stimulation and resective surgery outcomes in patients with co-occurring autism and epilepsy to patients with epilepsy alone: A population-based study.

2023

Autism research : official journal of the International Society for Autism Research

Subramaniam VR, Mu L, Kwon CS

Plain English
Using 12 years of national inpatient data, this study compared complications and outcomes of epilepsy surgery — both vagus nerve stimulation and brain resection — in patients with autism and epilepsy versus patients with epilepsy alone. There were no significant differences in in-hospital death, discharge status, length of stay, costs, or surgical complications between the two groups. The findings counter common concerns about surgical risk in autism and support offering epilepsy surgery evaluation to eligible patients with both conditions.

PubMed

Efficacy of Occipital Nerve Stimulation in Trigeminal Autonomic Cephalalgias: A Systematic Review.

2023

Neurosurgery

Veilleux C, Khousakoun D, Kwon CS, Amoozegar F, Girgis F

Plain English
This systematic review pooled outcomes from 417 patients across 14 studies to evaluate occipital nerve stimulation (ONS) for trigeminal autonomic cephalalgias, a group of severe, recurring headache disorders. Roughly 60% of patients with cluster headaches and similar conditions achieved more than 50% reduction in attack frequency, with average reductions in headache intensity, duration, and medication use. While about one-third required repeat surgery due to device complications, ONS represents a meaningful option for patients whose headaches do not respond to medication.

PubMed

Association of seizure with COVID-19 vaccines in persons with epilepsy: A systematic review and meta-analysis.

2023

Journal of medical virology

Rafati A, Jameie M, Amanollahi M, Jameie M, Pasebani Y +7 more

Plain English
This meta-analysis of 16 studies pooled data from over 3,000 people with epilepsy to assess seizure changes after COVID-19 vaccination. About 5% experienced increased seizure frequency after vaccination, with no significant difference between mRNA and viral vector vaccines, and the rate of life-threatening status epilepticus was only 0.08%. These rates are far lower than seizure risks from actual COVID-19 infection, reinforcing the recommendation that people with epilepsy get vaccinated.

PubMed

Non-small cell lung cancer withexon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes.

2022

Current medical research and opinion

Kwon CS, Lin HM, Crossland V, Churchill EN, Curran E +3 more

Plain English
This systematic review and meta-analysis summarized survival and response outcomes for non-small cell lung cancers carrying a specific EGFR exon 20 insertion mutation, which does not respond well to standard EGFR-targeted drugs. Standard chemotherapy outperformed EGFR inhibitors and immunotherapy in first-line treatment (overall survival 18 months vs. much shorter with other options), but outcomes dropped sharply in later lines of therapy. Newly approved agents specifically targeting this mutation — mobocertinib and amivantamab — offer promise, underscoring the importance of genetic testing to identify these patients.

PubMed

Genome-Wide Gene Expression Profiling Defines the Mechanism of Anticancer Effect of Colorectal Cancer Cell-Derived Conditioned Medium on Acute Myeloid Leukemia.

2022

Genes

Lee JE, Kwon CS, Jeon BE, Kim WR, Lee DH +3 more

Plain English
This study made the unexpected discovery that medium collected from colorectal cancer cells in culture could kill AML cells by triggering both cell death and differentiation. Genome-wide gene expression analysis showed that the medium suppressed cancer survival pathways and upregulated maturation-promoting genes, suggesting it contains secreted molecules with anti-leukemic activity. Identifying and isolating those molecules could open a novel approach to AML treatment based on tumor-derived factors.

PubMed

Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy.

2022

Epilepsia

Jehi L, Jette N, Kwon CS, Josephson CB, Burneo JG +19 more

Plain English
An international panel of 61 epilepsy specialists from 28 countries used a three-round Delphi process to produce expert consensus on when to refer a patient with epilepsy for surgical evaluation. The main recommendation is that all patients with drug-resistant epilepsy up to age 70 should be offered a surgical evaluation as soon as drug resistance is established, regardless of epilepsy type, psychiatric history, or social factors. The panel found no evidence to support delaying referral and emphasized that early evaluation reduces the morbidity and mortality of uncontrolled seizures.

PubMed

Autism Spectrum Disorder and Epilepsy.

2022

Neurologic clinics

Kwon CS, Wirrell EC, Jetté N

Plain English
This overview summarizes the well-documented relationship between autism spectrum disorder (ASD) and epilepsy, including the bidirectional increased risk each condition poses for the other and the diagnostic challenges that arise when stereotyped behaviors mimic seizures. Progress has been made in identifying which antiseizure medications work best in this population, but gaps remain in understanding how to screen for ASD in epilepsy, how specific genetic mutations shape ASD presentation, and how seizure activity itself worsens or modulates ASD symptoms. The review calls for more research into these interconnections to improve care for a clinically complex population.

PubMed

Trocar site hernia after laparoscopy: Early recognition prevents catastrophic sequelae.

2022

The Journal of emergency medicine

Kwon CS, Vaseeharan A, Sauer MV

Plain English
This case report describes a 25-year-old woman who developed a small bowel hernia through a 12-mm laparoscopic incision site within 48 hours of surgery to remove an ectopic pregnancy. Prompt CT imaging by emergency physicians identified the hernia before bowel necrosis could occur, and emergency repair was successful. The case highlights that trocar site hernia is rare but time-sensitive and should be on the differential diagnosis for any patient presenting with abdominal pain after laparoscopic surgery.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.